Two insurance-first philosophies: Ro bets on navigation plus direct brand access; Found bets that a coaching program wrapped around the prescription is what actually produces results.
The two models
Ro plays the insurance-navigation game better than most of the category: coverage checks, prior-authorization support, and — since its 2025 arrangement to dispense Lilly’s Zepbound vials — a direct lane to brand product at manufacturer self-pay prices. Its own fees, effective monthly totals, and compounded posture remain in our verification queue, so no Ro figure appears here yet.
Found bundles medication access with structured coaching and insurance navigation — a genuinely different product than pure medication funnels, aimed at people who want a program around the prescription. Program fees versus medication costs, and what the coaching layer actually adds, sit in our pending queue.
Verified vs pending — read this before the marketing
Neither provider on this page has completed price verification, so this comparison stays structural — business models, pricing architecture, and the questions each must answer — with zero advertised numbers repeated as facts. The only verified figures on this site today sit in the ledger.
Navigation versus accompaniment
Ro’s value case peaks at the approval moment — coverage found, brand vials dispensed, done. Found’s case is longitudinal — the weekly accountability that determines whether month nine looks like month two. Which matters more depends on whether your risk is getting the drug or sticking with the program; the quiz asks exactly that. Both providers’ true fee stacks remain queued, which is why this page names no totals.
Go deeper
Full files: Ro · Found. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.